As of 2026-08-09, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 52.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 73.31 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -27.8%.
The range of the Relative Valuation is (8.25) - 121.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 26.0x | 22.2x |
| Forward P/E multiples | 23.0x - 26.3x | 25.2x |
| Fair Price | (8.25) - 121.20 | 52.90 |
| Upside | -111.2% - 65.3% | -27.8% |
| Date | P/E |
| 2026-08-07 | -158.44 |
| 2026-08-06 | -153.12 |
| 2026-08-05 | -149.57 |
| 2026-08-04 | -149.34 |
| 2026-08-03 | -147.21 |
| 2026-07-31 | -146.98 |
| 2026-07-30 | -163.21 |
| 2026-07-29 | -160.99 |
| 2026-07-28 | -162.93 |
| 2026-07-27 | -163.82 |
| 2026-07-24 | -166.02 |
| 2026-07-23 | -169.54 |
| 2026-07-22 | -169.44 |
| 2026-07-21 | -169.65 |
| 2026-07-20 | -168.59 |
| 2026-07-17 | -169.85 |
| 2026-07-16 | -169.70 |
| 2026-07-15 | -170.39 |
| 2026-07-14 | -168.70 |
| 2026-07-13 | -175.77 |
| 2026-07-10 | -183.38 |
| 2026-07-09 | -193.53 |
| 2026-07-08 | -191.41 |
| 2026-07-07 | -192.78 |
| 2026-07-06 | -184.65 |
| 2026-07-02 | -180.05 |
| 2026-07-01 | -175.81 |
| 2026-06-30 | -176.29 |
| 2026-06-29 | -176.29 |
| 2026-06-26 | -182.47 |
| 2026-06-25 | -182.64 |
| 2026-06-24 | -182.42 |
| 2026-06-23 | -177.50 |
| 2026-06-22 | -174.97 |
| 2026-06-18 | -170.69 |
| 2026-06-17 | -169.72 |
| 2026-06-16 | -158.35 |
| 2026-06-15 | -165.91 |
| 2026-06-12 | -162.39 |
| 2026-06-11 | -161.46 |
| 2026-06-10 | -158.52 |
| 2026-06-09 | -159.23 |
| 2026-06-08 | -153.16 |
| 2026-06-05 | -153.38 |
| 2026-06-04 | -152.66 |
| 2026-06-03 | -148.43 |
| 2026-06-02 | -147.46 |
| 2026-06-01 | -159.49 |
| 2026-05-29 | -159.60 |
| 2026-05-28 | -153.55 |